The expression profile of genes encoding tumor necrosis factor-alpha, interleukin-6 and their receptor in benign adrenal tumors.
Adrenal Gland Neoplasms
/ complications
Aged
Cushing Syndrome
/ etiology
Female
Gene Expression Profiling
Humans
Hyperaldosteronism
/ etiology
Interleukin-6
/ genetics
Male
Middle Aged
Predictive Value of Tests
Receptors, Interleukin-6
/ drug effects
Receptors, Tumor Necrosis Factor, Type I
/ genetics
Receptors, Tumor Necrosis Factor, Type II
/ genetics
Transcriptome
Tumor Necrosis Factor-alpha
/ genetics
Journal
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
ISSN: 1899-1505
Titre abrégé: J Physiol Pharmacol
Pays: Poland
ID NLM: 9114501
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
21
07
2020
accepted:
30
08
2020
entrez:
14
12
2020
pubmed:
15
12
2020
medline:
25
8
2021
Statut:
ppublish
Résumé
In the process of neoplasia, during which benign adrenal tumors are formed, stimulators of new blood vessel growth as well as growth of tumor cells are cytokines, especially tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6). We analyzed the expression profile of genes coding: TNF-α, tumor necrosis factor receptor 1 (TNF-R1), TNF-R2, IL-6, interleukin 6 receptor (IL-6R) in sections of adrenocortical tumor tissue, rated on the Weiss point scale, in patients with clinically diagnosed Conn's and Cushing's syndrome, and the usefulness of determining the examined genes as markers differentiating individual clinical units. There was no correlation between the expression of the examined genes and clinical parameters such as age, BMI or blood pressure, both in the entire study group and in individual subgroups. Elevated expression of the genes coding TNF-α, TNF-R2 and IL-6R was observed, whereas genes encoding TNF-R1 and IL-6 showed relatively low expression. The highest statistically significant differences in the expression of the examined genes were observed between IL-6 and IL-6R. High positive correlation was found in the subgroup of patients with Conn's clinical syndrome, between genes encoding both types of receptors for TNF-α, IL-6 and TNF-R2, TNF-α and IL-6 receptor, and between TNF-R2 and IL6-R receptors, which may suggest the mutual influence of these cytokines and their receptors on their own expression.
Identifiants
pubmed: 33316770
doi: 10.26402/jpp.2020.4.11
doi:
Substances chimiques
IL6 protein, human
0
IL6R protein, human
0
Interleukin-6
0
Receptors, Interleukin-6
0
Receptors, Tumor Necrosis Factor, Type I
0
Receptors, Tumor Necrosis Factor, Type II
0
TNF protein, human
0
TNFRSF1A protein, human
0
TNFRSF1B protein, human
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM